ArticleScientific reports2026
Morphology-guided deep learning for nanoparticle agglomeration diagnostic assays.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Accurate and rapid diagnostic tests that are simultaneously affordable remain elusive, typically due to trade-offs between performance and cost. Conventional nucleic acid tests offer high sensitivity but require complex, expensive steps such as amplification and purification, whereas lateral flow assays are simple and low-cost but lack the necessary sensitivity for many applications. New analytical approaches provide an opportunity to bridge this gap, raising sensitivity but not material expense. We present a miniaturized and simplified chip-based platform that combines three components into a single diagnostic pipeline: we use (i) spectrally distinct silver and gold nanoparticles (NPs) that form analyte-dependent clusters with unique spectral fingerprints, (ii) a one-pot, enzyme- and purification-free assay on a chip integrated with a high-throughput automated low-cost microscope, and (iii) a morphology-guided convolutional Graph Neural Network that embeds morphology information into convolutional kernels and performs graph-based relational learning across particle-level features. This integration captures spectral, spatial, and morphological quantification at the particle level, rather than relying on bulk spectral shifts, thereby addressing key limitations observed in representative nanoparticle (NP) assays and image-level deep learning baselines under particle-parallel analysis. Mc-GNN is able to process up to 5,000 particle crops per image in a single computational step, using less than 2 GB of GPU memory. This allows us to achieve femtomolar sensitivity with 98.2% recall for synthetic DNA and 94.8% for SARS-CoV-2 RNA from whole viruses, within in-domain experimental variability arising from different NP combinations and assay conditions. By embedding morphological information into the biosensing pipeline, our diagnostic platform is computationally efficient with millisecond-scale neural compute per raw image on a single consumer-grade GPU and is readily extensible to new analytes and multiplexing, offering a scalable solution for a fieldable diagnostic tool.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.